Outsourced Pharma Webinars

  1. Global Manufacturing Excellence Across Quality, Efficiency, And Cost Of Goods Sold 3/26/2026

    Learn strategies to strengthen global biologics manufacturing through consistent quality, advanced technologies, and efficient tech transfer to improve operations and commercial readiness.

  2. Ensure Successful Viral Clearance 3/26/2026

    A decade of viral clearance data comparing established and emerging operations, highlighting LRV performance, key process risks, and practical insights to strengthen downstream safety.

  3. Deciphering The Complexity Of Therapeutic Biologics 3/26/2026

    This session breaks down essential analytical approaches that strengthen biologics development, from defining critical quality attributes to supporting comparability and regulatory readiness. 

  4. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.

  5. Evaluating Novel Whole Blood Preservation Methods As Alternatives To PBMC 3/22/2026

    Discover how alternative whole blood preservation methods can improve specimen stability, streamline global clinical trial logistics, and enhance immunophenotyping results.

  6. Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development 3/19/2026

    Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.

  7. How AI-Enabled Validation Technologies Enable The Predictive Plant 3/18/2026

    Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.

  8. Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems 3/18/2026

    Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.

  9. Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery 3/17/2026

    Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.

  10. What Matters More In DNA-Encoded Libraries? 3/16/2026

    DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.